Randomized, double-blind, placebo-controlled, multiple dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of YTX-7739, a novel oral inhibitor of Stearoyl-CoA-desaturases, in patients with Parkinson's Disease
- Bertram, Kelly (Primary Chief Investigator (PCI))
- Kerris, Jarrod, Alfred Health (Project Manager)
Project: Research